Please login to the form below

Not currently logged in

Bedrock announces a number of new hires

Appointments include Emily Wigginton who joins as head of client services

Bedrock Healthcare Communications has announced a number of new hires to its team since the beginning of 2021.

This includes Emily Wigginton (pictured above), who has been appointed as head of client services. Wigginton brings a wealth of healthcare comms experience to Bedrock.

Most recently, she served as client services director at OPEN Health Patient & Brand Communications. Prior to this, she worked at Life Healthcare Communications and PAN Advertising UK.

Also joining Bedrock is Chris Barton, who has been appointed as strategic solutions director. Barton has previous sales and marketing experience gained from roles at AstraZeneca, Baxter, Abbott, AbbVie and Novartis.

He worked at Novartis for a period of four years, most recently as community team leader, cardiovascular. Before this, he was a market access manager at AbbVie.

Stephanie Wasek has been appointed scientific director at Bedrock. Previously, Wasek has held a number of roles within the healthcare communications sector, at agencies including Lucid Group and Synergy Vision.

Most recently, she worked as a principal medical writer at Lucid Group, and as creative engagement lead at Synergy Vision.

Rounding out the appointments at Bedrock is Louise Higley, who joins as executive assistant and office manager.

She is set to support both Bedrock Healthcare communications and Origins Insights as part of her new role.

Article by
Lucy Parsons

12th March 2021

From: Marketing


COVID-19 Updates and Daily News

Featured jobs


Add my company
Innovative Trials

Innovative Trials is a leading global clinical trial patient recruitment company. With over 10 years’ experience, Innovative Trials deploys “boots-on-the-ground”...

Latest intelligence

When is an agency not an agency?
The PR Week UK Top 150 Consultancies prompts anticipation and curiosity. But can a virtual collective of freelancers fairly be compared and ranked against conventional agencies?...
Why big pharma needs to be braver
The last few years have seen the pharmaceutical industry undergo a rapid metamorphosis in the face of unprecedented change, but communications are one area that still needs an injection of...
Leveraging Real-World Evidence for Cell and Gene Therapies
Regulators and reimbursement bodies are increasingly turning to real-world evidence (RWE) to understand the long-term value of drugs, in particular novel therapies. Here, Mariam Bibi, Senior Director, Global RWE at...